PRESS RELEASE: TORONTO, March 28, 2018 /CNW/ – Strainprint, the leader in cannabis data collection and strain efficacy reporting, is thrilled to announce the launch of Strainprint Analytics, a powerful web-based data platform for visually mining the world’s largest data set on strain efficacy and real-time patient use. On March 27, Strainprint gathered with key […]
Whether you are a medical cannabis patient or a recreational user, tracking your cannabis consumption habits are not only essential but also largely beneficial. Some people find it helpful to chronical their treatment journey in a paper-based journal but often find it inconvenient to capture each interaction and thus have an inaccurate record of […]
Seniors are among one of the largest existing and largest growing demographics of medical cannabis users , evidenced by international trends as well as is supported by the data collected from the Strainprint app. A report released late 2017 by Statistics Canada, indicated that older generations are the demographics consuming larger amounts of cannabis within […]
February 05, 2018 – Strainprint was featured in the Daily Marijuana Observer which discusses 5 of the Most Common Ailments Being Treated with Medical Marijuana
If you have a medicinal, recreational or scientific interest in the cannabis plant, the term “terpenes” has most likely popped up as you educate yourself on cannabis and the way it interacts with the human body. The importance of terpenes in all species of plants, especially cannabis, can’t be underestimated. Terpenes are fundamental building blocks […]
Our President and Chief Technology Officer, Dave Berg was recently featured in the The Daily Marijuana Observer – Get to know all about what makes Dave tick, and why he’s so passionate about Strainprint.
Recently, the Strainprint App was featured on Blyss Cloud. Read all about why they love the Strainprint App!
When talking about cannabis, there are two main cannabinoids that make their way into most cannabis discourses: THC and CBD. While each are of equal value amongst the hundreds of cannabinoid compounds within the cannabis plant, they serve very different functions for the user and achieve different effects.
On August 30th, 2017 Strainprint was featured on the Investing News Network. Our President, Dave Berg spoke to the Investing News Network about Strainprint and how we’re working to change the limitations of Medical Cannabis Research.